SpyGlass Pharma remote jobs and company guide
SpyGlass Pharma develops sustained drug delivery systems for chronic eye diseases, combining glaucoma and cataract treatment through its innovative BIM-IOL System that delivers medication over multiple years.
About SpyGlass Pharma
SpyGlass Pharma was founded in 2019 by Dr. Malik Y. Kahook, MD and Glenn Sussman to redefine the treatment of chronic ophthalmic diseases through sustained drug delivery. Based in Aliso Viejo, California, the company is focused on developing innovative solutions for patients suffering from chronic eye conditions, particularly glaucoma and cataracts. With over 15 years of partnership between its founders, SpyGlass combines complementary expertise from ophthalmic surgery, medical device engineering, and product development to address significant unmet needs in eye care.
The company's lead product, the SpyGlass BIM-IOL System, integrates long-acting glaucoma medication delivery into an intraocular lens (IOL) implanted during routine cataract surgery. This novel approach enables sustained drug release over multiple years while restoring clear vision, potentially treating millions of patients with both conditions in a single procedure. SpyGlass Pharma is advancing through Phase 3 clinical trials and has secured significant funding, including a $75 million Series D financing round, demonstrating strong investor confidence in their drug delivery platform technology.
Remote roles and application process
SpyGlass Pharma roles are commonly associated with Ophthalmology, Glaucoma Therapeutics, Clinical Stage Life Sciences (Phase 3 Trials), Cataract Surgery, Sustained Release Drug Delivery.
Review current openings on SpyGlass Pharma's official careers page before applying.
Latest SpyGlass Pharma remote jobs
No active public remote jobs are listed for this company right now. Check back as new roles are ingested.
See all SpyGlass Pharma jobsWhat it is like working at SpyGlass Pharma
SpyGlass Pharma remote jobs FAQ
When was SpyGlass Pharma founded?
SpyGlass Pharma was founded in 2019.
Who is the CEO of SpyGlass Pharma?
Patrick Mooney is the CEO.
What industries or markets does SpyGlass Pharma operate in?
SpyGlass Pharma operates in the following markets: Ophthalmology, Glaucoma Therapeutics, Clinical Stage Life Sciences (Phase 3 Trials), Cataract Surgery, Sustained Release Drug Delivery, Combination Drug Device Products, Implantable Medical Devices, Intraocular Lenses (IOL), Specialty Pharmaceuticals, and Biopharma.
How many employees does SpyGlass Pharma have?
SpyGlass Pharma has 11-50 employees.
Where does SpyGlass Pharma have employees?
SpyGlass Pharma has employees in United States.
Is SpyGlass Pharma hiring?
Yes, SpyGlass Pharma has 2 open remote job s .
Does SpyGlass Pharma support remote work or working from home?
Yes, SpyGlass Pharma is a remote-friendly company.
Does SpyGlass Pharma offer a four-day work week?
No, SpyGlass Pharma does not offer a four-day work week.
